Theranexus (EPA:ALTHX) | Finanzwire

Basculer en Français

10109	Companies
207174	Keywords
137295	Articles
109800	Press releases

Home
Companies
Theranexus

PRESS RELEASE

published on 09/29/2025 at 18:30, 6 months ago

Theranexus Becomes THX Pharma: A Strategic Evolution Toward the Commercialization of Its Medicines for Rare Diseases
THX Pharma (formerly Theranexus) announces strategic focus on regulatory approval, early access, and global commercialization of new drug candidates for rare neurological diseases

Regulatory Approval Commercialization Rare Neurological Diseases THX Pharma Early Access
BRIEF

published on 09/25/2025 at 18:05, 6 months 4 days ago

Theranexus publishes its financial results for the first half of 2025

Financial Results Cost Reduction Theranexus Batten-1 TX01
PRESS RELEASE

published on 09/25/2025 at 18:00, 6 months 4 days ago

THERANEXUS ANNOUNCES FIRST HALF 2025 FINANCIAL RESULTS
Theranexus announces first half 2025 financial results showing a decrease in operating expenses and a net loss of €1,072 K. Focus on developing flagship asset TX01 and advancing Batten-1

Financial Results Theranexus Batten-1 Operating Expenses TX01
BRIEF

published on 07/17/2025 at 18:05, 8 months 12 days ago

Half-Yearly Review of the Theranexus Liquidity Contract

Liquidity Contract PORTZAMPARC Financial Statement Biopharmaceuticals Theranexus
BRIEF

published on 07/10/2025 at 18:05, 8 months 19 days ago

Theranexus Reveals its Cash Position as of June 30, 2025

Treasury Biopharmaceutical Innovation Theranexus Batten-1 Neurological Diseases
PRESS RELEASE

published on 07/10/2025 at 18:00, 8 months 19 days ago

THERANEXUS PUBLISHES ITS CASH POSITION AS OF 30 JUNE 2025
Theranexus, a biopharmaceutical company, reports a cash position of €2.1M as of 30 June 2025, with upcoming funds and financial visibility through Q2 2026. CEO discusses collaborations and strategic progress. H1 2025 results expected on September 25, 2025

Cash Position Biopharmaceutical Financial Publication Theranexus Rare Neurological Diseases
BRIEF

published on 05/13/2025 at 18:05, 10 months 16 days ago

Theranexus and BBDF reveal promising results for Batten-1

Theranexus Batten-1 BBDF Batten Disease Visual Acuity
PRESS RELEASE

published on 05/13/2025 at 18:00, 10 months 16 days ago

THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION ANNOUNCE STRONG POSITIVE REAL-WORLD DATA SUPPORTING BATTEN-1 EFFICACY FOR THE TREATMENT OF BATTEN DISEASE
Theranexus and BBDF announce new data supporting Batten-1 (miglustat) efficacy for CLN3 disease treatment. Results show significant preservation of visual acuity in treated patients over 12 months. Real-world analysis aligns with Phase 3 trial design

Theranexus Batten-1 BBDF Visual Acuity CLN3 Disease
BRIEF

published on 04/29/2025 at 19:05, 11 months ago

Theranexus: 2024 Annual Review and New Perspectives

Financial Results Partnerships Theranexus Batten-1 Grants
PRESS RELEASE

published on 04/29/2025 at 19:00, 11 months ago

THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT AND CLOSES ITS EQUITY LINE
Theranexus publishes financial results for 2024 & cash position as of March 31, 2025, presents progress report & plans for Batten-1 drug candidate. Board approves accounts. Continues strategic partnerships & developments

Financial Results Strategic Partnerships Clinical Trials Theranexus Batten-1

Accesswire

Published on 03/29/2026 at 12:15, 9 hours 6 minutes ago

China Xlx Announces 2025 Annual Results Deepening Efforts in Reducing Costs, Enhancing Efficiency, Strengthening Competitiveness Through Differentiation and Driving Marketing Transformation
Published on 03/28/2026 at 01:00, 1 day 19 hours ago

Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 1 day 19 hours ago

Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 1 day 19 hours ago

"Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 1 day 21 hours ago

Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder

View all ACCESSWIRE

EQS Group

Published on 03/29/2026 at 17:05, 4 hours 16 minutes ago

FAST III trial demonstrates non-inferiority of CAAS vFFR to invasive wire-based FFR
Published on 03/28/2026 at 10:05, 1 day 11 hours ago

Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 1 day 12 hours ago

Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 1 day 18 hours ago

EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 1 day 22 hours ago

Kaufman & Broad SA: Availability of the Universal Registration Document 2025

Les Echos

Published on 03/27/2026 at 19:06, 2 days 2 hours ago

Mersen: Disclosure of trading own shares
Published on 03/27/2026 at 18:52, 2 days 2 hours ago

Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:40, 2 days 2 hours ago

2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
Published on 03/27/2026 at 17:53, 2 days 3 hours ago

Publication of Carrefour's 2025 Universal Registration Document
Published on 03/27/2026 at 17:45, 2 days 3 hours ago

PUBLICATION OF THE UNIVERSAL REGISTRATION DOCUMENT FISCAL YEAR 2025

View all LES ECHOS COMFI WIRE